Physician profile
Marc Coel
NPI 1093784993
$583.20
in general payments reported to CMS, 2019-2025
8 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.64 · 2020: $37.47 · 2021: $24.85 · 2022: $68.93 · 2023: $33.22 · 2024: $102 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $260.11 | 2023-2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Y90 Glass Microspheres 7.0 Gbq (US Commercial) |
| Novartis Pharmaceuticals Corporation | $95.97 | 2021-2024 | |
| Astellas Pharma US INC | $77.61 | 2019-2020 | |
| Siemens Medical Solutions USA, INC. | $37.93 | 2023-2025 | Naeotom Alpha, Magnetom Skyra, Acuson Sequoia Diagnostic Ultrasound System |
| Bayer Healthcare Pharmaceuticals INC. | $37.44 | 2020-2024 | |
| Pfizer INC. | $37.00 | 2024 | |
| Telix Pharmaceuticals | $19.40 | 2022 | |
| Ge Healthcare | $17.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Coel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.